Global guidewires market is forecasted to attain revenue of $1,126.5 million by 2023, according to P&S Market Research.The growth is led by favorable reimbursement scenario, increasing prevalence of chronic and lifestyle associated disorders, and growing demand for minimally invasive surgeries (MISs).

Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/guidewires-market

On the basis of material type, the market has been categorized into nitinol, stainless steel and hybrid type. Nitinol material is predicted to lead the guidewires market, in terms of size and as well as growth. The category held an estimated contribution of 47.2% in the global market in 2017 and is expected to progress at a CAGR of 5.9% during the forecast period. This leading position is mainly attributable to various features of these products such as high elastic property that provides kink resistance, better trackability and offers reduced prolapse, when compared to stainless steel and other materials.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/guidewires-market/report-sample

These products find application in coronary, peripheral, urology, neurovascular, gastroenterology and other health related disorders. Among these the neurovascular application category is expected to witness fastest growth in demand, growing at a CAGR of 6.7% during the forecast period, owing to the increasing number of neurovascular disorders globally.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=guidewires-market

The APAC guidewires industry is expected to witness the fastest growth in demand, at a CAGR of 6.4%, during the forecast period, owing to growing aging population, increasing prevalence of chronic diseases, growing medical tourism and continuously improving healthcare infrastructure.

Some of the other key players operating in the guidewires market are Cardinal Health Inc., Stryker Corporation, B. Braun Melsungen AG, CONMED Corporation, Medtronic PLC, Asahi Intecc Co. Ltd., Abbott Laboratories, and Terumo Corporation.

Source: Click here